Menu Close

Articles on COVID vaccines

Displaying 41 - 60 of 78 articles

Study shows that the Novavax vaccine is effective against the dominant variant of COVID-19 in South Africa. Jakub Porzycki/NurPhoto via Getty Images

Results from Novavax vaccine trials in the UK and South Africa differ: why, and does it matter?

The results indicate that the vaccine efficacy in the UK was 89% for individuals who received at least two doses of vaccine. In South Africa, the vaccine efficacy was 60% in people without HIV.
A market place in Ghana’s capital Accra. Developing countries like Ghana risk being left behind in the race to secure COVID-19 vaccines. Christian Thompson/Anadolu Agency via Getty Images

Dummy’s guide to how trade rules affect access to COVID-19 vaccines

A waiver on some intellectual property rules at the WTO for COVID-19 vaccines would ensure more equitable access, but wouldn't solve all the problems facing developing countries.

Top contributors

More